Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 4
1977 2
1978 2
1979 1
1980 3
1981 1
1982 5
1984 1
1985 2
1986 5
1987 2
1988 2
1989 6
1990 11
1991 15
1992 13
1993 14
1994 8
1995 12
1996 7
1997 7
1998 13
1999 9
2000 15
2001 7
2002 14
2003 14
2004 15
2005 14
2006 16
2007 13
2008 18
2009 12
2010 5
2011 10
2012 8
2013 4
2014 6
2015 9
2016 7
2017 9
2018 9
2019 6
2020 8
2021 6
2022 6
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Results by year

Filters applied: . Clear all
Page 1
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Colhoun HM, et al. Among authors: durrington pn. Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.
Diabetic dyslipidaemia.
Soran H, Schofield JD, Adam S, Durrington PN. Soran H, et al. Among authors: durrington pn. Curr Opin Lipidol. 2016 Aug;27(4):313-22. doi: 10.1097/MOL.0000000000000318. Curr Opin Lipidol. 2016. PMID: 27213628 Review.
Dyslipidaemia.
Durrington P. Durrington P. Lancet. 2003 Aug 30;362(9385):717-31. doi: 10.1016/S0140-6736(03)14234-1. Lancet. 2003. PMID: 12957096 Review.
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
European Association for Cardiovascular Prevention & Rehabilitation; Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. European Association for Cardiovascular Prevention & Rehabilitation, et al. Among authors: durrington p. Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158. Epub 2011 Jun 28. Eur Heart J. 2011. PMID: 21712404 Free article.
Paraoxonase 1 and atherosclerosis.
Durrington PN, Bashir B, Soran H. Durrington PN, et al. Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36873390 Free PMC article. Review.
Lipoprotein (a).
Durrington PN. Durrington PN. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):773-95. doi: 10.1016/s0950-351x(95)80145-6. Baillieres Clin Endocrinol Metab. 1995. PMID: 8593125 Review.
Lipoprotein (a) in familial hypercholesterolaemia.
Durrington PN, Bashir B, Bhatnagar D, Soran H. Durrington PN, et al. Curr Opin Lipidol. 2022 Aug 1;33(4):257-263. doi: 10.1097/MOL.0000000000000839. Curr Opin Lipidol. 2022. PMID: 35942820 Review.
Paraoxonase and atherosclerosis.
Durrington PN, Mackness B, Mackness MI. Durrington PN, et al. Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):473-80. doi: 10.1161/01.atv.21.4.473. Arterioscler Thromb Vasc Biol. 2001. PMID: 11304460 Review.
Editorial introduction.
Durrington PN. Durrington PN. Curr Opin Lipidol. 2017 Aug;28(4):v. doi: 10.1097/MOL.0000000000000439. Curr Opin Lipidol. 2017. PMID: 28700378 No abstract available.
365 results